{
    "nct_id": "NCT05689164",
    "official_title": "Long-term Follow-up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study",
    "inclusion_criteria": "* Participants who received fordadistrogene movaparvovec in a previous Pfizer interventional study.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 0 Years",
    "exclusion_criteria": "* Investigator site staff directly involved in the study and their family members",
    "miscellaneous_criteria": ""
}